Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$104,982,446
-$41,484,889 QoQ
Shares Held
417,193
-38.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#248
of 4,153 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITOLIS LIQUID GLOBAL MARKETS LLC holds $760,749,519 across 8 Drug Manufacturers - General names. ABBV ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,054,146 | $267,721,459 | |
| 2 | LLY |
ELI LILLY & Co
|
177,877 | $213,351,027 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
417,193 | $104,982,446 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
643,915 | $81,352,221 | |
| 5 | MRK |
Merck & Co., Inc.
|
571,730 | $73,467,305 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
240,100 | $13,834,562 | |
| 7 | AMGN |
Amgen Inc
|
13,775 | $4,988,203 | |
| 8 | PFE |
Pfizer Inc
|
43,700 | $1,052,296 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,982,446 | 417,193 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $146,467,335 | 673,444 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||